YSB Inc. (FRA:B1S)

Market Cap	277.84M -65.1%
Revenue (ttm)	2.76B +13.1%
Net Income	23.93M +115.1%
EPS	0.04 +107.8%
Shares Out	n/a
PE Ratio	10.35
Forward PE	n/a
Dividend	0.01 (3.74%)
Ex-Dividend Date	May 26, 2026

Volume	n/a
Open	0.3660
Previous Close	0.3780
Day's Range	0.3660 - 0.3660
52-Week Range	0.3020 - 1.1000
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 20, 2026

About YSB Inc.

YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2015
• Employees: 6,795
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: B1S

Financial Performance

In 2025, YSB Inc.'s revenue was 20.97 billion, an increase of 17.13% compared to the previous year's 17.90 billion. Earnings were 152.97 million, an increase of 409.66%.

Financial numbers in CNY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 26, 2026

Data Sources Report a data error